Batu Biologics Names Investor To Board

San Diego-based Batu Biologics, a developer of immune therapy drugs aimed at treating cancer, has added investor John Peck Jr. to its Board of Directors. The company said Peck has been involved with the company as an early-stage seed round investor. Peck is a real estate and biotech investor, and had been CEO and one ofthe owners of Meridian Leasing, although he got his start working for RCA and Intel as an MBA student in the 1960's. The company said Peck is an investor in seven biotech companies.